Health Moderna Halts Development of CMV Vaccine After Phase 3 Failure Moderna has announced that its vaccine for cytomegalovirus (CMV) has failed to meet efficacy requirements in a Phase 3 clinical trial. As a result,... Editorial7 hours ago